Waive risk-based inspections, urges MSME pharma body

Laghu Udyog Bharati requests the government to waive risk-based inspections for companies upgrading their facilities. The association seeks an extension for Schedule M implementation for smaller firms. Concerns arise over inspections being conducted like raids. LUB highlights the role of MSMEs in supplying medicines during Covid. They request special attention for manufacturers with less than Rupees 50 crore turnover.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wdtkQ0B
via IFTTT